DYNABAC 250 MG ENTERIC COATED TABLET

DRUG4 trials

Sponsors

Pharmaceutical Research Unit, Jordan

Conditions

Healthy

Phase 1

Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fed Condition

CompletedNCT02185846

Pharmaceutical Research Unit, JordanHealthy

Start: 2014-06-30End: 2014-06-30Updated: 2014-07-10

Bioequivalence Pilot Study of Dirithromycin of (Abdi İbrahim İlaç San.Ve.Tic.A.Ş,Turkey) in Healthy Subjects Under Fasting Condition

CompletedNCT02185833

Pharmaceutical Research Unit, JordanHealthy

Start: 2014-06-30End: 2014-06-30Updated: 2014-07-10

Semi-replicate Crossover Bioequivalence Study of Dirithromycin of (Abdi İbrahim İlaç San. Ve Tic. A. Ş., Turkey) in Healthy Subjects Under Fasting Conditions

CompletedNCT02237768

Pharmaceutical Research Unit, JordanHealthy

Start: 2014-12-31End: 2014-12-31Updated: 2020-09-18

Semi-replicate Crossover Bioequivalence Study of Dirithromycin in Healthy Subjects Under Fed Conditions

CompletedNCT02237807

Pharmaceutical Research Unit, JordanHealthy

Start: 2014-09-30End: 2014-10-31Updated: 2020-09-18